MedPath

福建省兴源集团（莆田）药业有限公司

Ownership
-
Established
1996-03-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

NMPA:21

Drug Approvals

Puerarin Injection

Product Name
葛根素注射液
Approval Number
国药准字H20058539
Approval Date
Mar 19, 2025
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20034010
Approval Date
Jan 14, 2022
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20023831
Approval Date
Jan 14, 2022
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20033979
Approval Date
Jan 14, 2022
NMPA

Fluconazole and Sodium Chloride Injection

Product Name
氟康唑氯化钠注射液
Approval Number
国药准字H20054865
Approval Date
Jan 14, 2022
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20034035
Approval Date
Jan 14, 2022
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20033984
Approval Date
Jan 14, 2022
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20033993
Approval Date
Jan 14, 2022
NMPA

Marine and Sodium Chloride Injection

Product Name
苦参素氯化钠注射液
Approval Number
国药准字H20041060
Approval Date
Jan 14, 2022
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20033986
Approval Date
Jan 14, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.